Innova Biosciences has launched its Antibody Conjugation Service that uses conjugation chemistry to label microgram to milligram amounts of antibodies in 48 hours.
Bio-conjugates can be challenging to optimise and time-consuming to produce.
Too much conjugation may result in the target protein becoming inactive and insoluble and too little conjugation can result in weak signals.
Innova Biosciences uses its proprietary technologies to enhance the performance of conjugates.
By creating an array of trial conjugates (10 formulations per label) at low microgram scale (10ug per formulation) combined with selection in the assay of interest, the best possible conjugate can be attained.
All conjugates produced using the company's micro-optimisation technology can be scaled over many orders of magnitude without the need for extensive re-development of the process.
The simplicity of Innova's technology means that high yields are obtained, with minimal batch-to-batch variation, ensuring consistent performance.
